Alcon

Alcon Investments

The Total Investments of Alcon (ALC.SW) as of Oct 5, 2026 is 610.34 M USD. In the previous year, Total Investments was 259.25 M USD — a change of 135.42% (higher).

Investments

610.34 MUSD

YoY

135.42%

Last updated:

Total Investments of Alcon is 2026 610.34 M USD. Total Investments of Alcon was 2025 259.25 M USD. It decreases by 135.42% higher compared to the previous year.

The Alcon Investments history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Investments
Date
Investments
Jan 1, 2017
41.45 M USD
Jan 1, 2018
37.38 M USD
Jan 1, 2019
47.95 M USD
Jan 1, 2020
32.51 M USD
Jan 1, 2021
42.26 M USD
Jan 1, 2022
87.77 M USD
Jan 1, 2023
259.25 M USD
Jan 1, 2024
610.34 M USD
The Alcon Investments history
YEARInvestmentsYoY
610.34 MUSD+135.42%
259.25 MUSD+195.37%
87.77 MUSD+107.69%
42.26 MUSD+30.00%
32.51 MUSD-32.20%
47.95 MUSD+28.26%
37.38 MUSD-9.80%
41.45 MUSD+628.57%
5.69 MUSD-36.36%
8.94 MUSD—
Access this data via the Eulerpool API

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcon stock

Total Investments of Alcon is 610.34 M USD in 2026.

Total Investments of Alcon changed from 259.25 M USD to 610.34 M USD, representing a 135.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Investments Alcon since 2006 – with annual values, charts, and detailed analysis.

Total investments include both short-term and long-term investment securities held by the company.

Total Investments's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Investments's Alcon historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Alcon

All Key Metrics — Alcon